XML 12 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Statement of Cash Flows [Abstract]    
Net loss attributable to the Company $ (824,880) $ (1,543,179)
Less: Net Income( loss) attributable to non-controlliong interest (1,630) 4,256
Net loss (826,510) (1,538,923)
Depreciation and amortization 70,128 85,921
Bad debt expense 43,900 101,090
Amortization of debt discount and deferred financing charges 16,602 95,000
Common Stock and options issued for services 211,402 445,712
Common Stock issued for settlement of litigation    18,000
Common Stock cancelled for acquisition    (902,500)
Amortization of deferred compensation 52,788 1,232,068
Change in fair market value of derivative liability    50,269
Decrease in deferred revenue    (199,022)
Increase in accrued officer's compensation 20,000   
Loss on sale of property and equipment 1,119 6,079
Changes in operating assets and liabilities:    
Decrease in security deposits 4,916   
Decrease in Accounts Receivable    5,570
(Increase) Decrease in prepaid expenses and other current assets (12,657) 122,466
Increase in Accounts Payable and Accrued Liabilities 142,929 146,250
Increase(decrease) in customer deposits payable (53,940) 53,940
Net cash (used in) operating activities (329,323) (278,080)
Investing Activities:    
Proceeds from liquidation of investments    3,563,062
Capital expenditures    (46,248)
Proceeds from sale of property and equipment 20,000 120,505
Effect of subsidiary disposition (5,898)   
Net cash provided by investing activities 14,102 3,637,319
Financing Activities:    
Cash Overdraft 1,309   
Payment for Notes Receivable    (20,000)
Proceeds from the sale of Common Stock 127,500 325,000
Redemption of Series B preferred stock    (3,250,000)
Redemption of common stock    (353,062)
Proceeds form loans payable 58,310 73,992
Payments of loan payables    (43,334)
Proceeds from convertible notes payable 75,000 95,000
Payments of convertible notes payable    (83,000)
Payments of notes payable (8,077) (56,130)
Net cash provided by (used in) financing activities 254,042 (3,311,534)
Effect of exchange rate change    348
Net increase (decrease) in cash and cash equivalents (61,179) 48,053
Cash and cash equivalents at beginning of period 61,179 13,126
Cash and cash equivalents at end of period    61,179
Cash paid during the period for:    
Interest expense 11,351 34,275
Income taxes      
Non-Cash Financing Activities:    
Issuance of Common Stock for payment of Accounts Payable 20,875 6,000
Forgiveness of accrued compensation to related party 700,269   
Common stock issued for payment of accrued compensation    125,000
Dividends payable on preferred stock - Series B    60,102
Discount on convertible notes payable 75,000 95,000
Reversal of dividends payable on preferred stock - Series B    265,787
Issuance of Common Stock upon conversion of convertible debt   12,000
Issuance of Common Stock as consideration for payment of loans payable    7,500
Common stock issued as consideration for accrued compensation to related party 366,000   
Accounts payable applied to option exercise $ 1,000